The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
暂无分享,去创建一个
J. Dipersio | M. Perales | M. Maiers | S. Spellman | C. Kollman | R. Hartzman | C. Hurley | M. Setterholm | C. Anasetti | R. Champlin | N. Yu | M. Eapen | C. Kollman | S. R. Spellman | M.-J. Zhang | A. Hassebroek | C. Anasetti | J. H. Antin | R. E. Champlin | D. L. Confer | J. F. DiPersio | M. Fernandez-Vina | R. J. Hartzman | M. M. Horowitz | C. K. Hurley | C. Karanes | M. Maiers | C. R. Mueller | M.-A. Perales | M. Setterholm | A. E. Woolfrey | N. Yu | M. Eapen | D. Confer | J. Antin | C. Karanes | Mei-Jie Zhang | C. Mueller | A. Woolfrey | A. Hassebroek | M. Horowitz | M. Fernández-Viña | Carlheinz R Mueller
[1] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[2] J. Wagner,et al. The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[3] Loren Gragert,et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.
[4] D. Cox. Regression Models and Life-Tables , 1972 .
[5] J. Klein,et al. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. , 2009, Blood.
[6] Robert N. Stavins,et al. ENVIRONMENTAL REGULATION IN THE 1990 S : A RETROSPECTIVE ANALYSIS , 2003 .
[7] R. Vij,et al. Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. , 2015, Blood.
[8] J. Wagner,et al. Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[9] Harriet Noreen,et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.
[10] M. Hirokawa,et al. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program , 2008, Haematologica.
[11] J. Wingard,et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. , 2011, Blood.
[12] M. Maiers,et al. Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] John P. Klein,et al. Discretizing a Continuous Covariate in Survival Studies , 2003, Advances in Survival Analysis.
[14] J. Klein,et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[15] Richard A. Miller. The Aging Immune System: Primer and Prospectus , 1996, Science.
[16] C Anasetti,et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. , 2001, Blood.
[17] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[18] H. Einsele,et al. Donor cytomegalovirus status influences the outcome of allogeneic stem cell transplant: a study by the European group for blood and marrow transplantation. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] K. Schwarz,et al. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis. , 2013, Blood.
[20] Medhat Askar,et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. , 2014, Blood.
[21] J. Wagner,et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.
[22] R. Brand,et al. Female‐Versus‐Male Alloreactivity as a Model for Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] K. Sullivan,et al. Pathophysiology and treatment of graft-versus-host disease. , 1999, Hematology/oncology clinics of North America.
[24] Brent R Logan,et al. A perspective on the selection of unrelated donors and cord blood units for transplantation. , 2012, Blood.
[25] R. Brand,et al. Risk score for outcome after allogeneic hematopoietic stem cell transplantation , 2009, Cancer.
[26] A. Gratwohl. The EBMT risk score , 2012, Bone Marrow Transplantation.